🇺🇸 FDA
Patent

US 10407476

Methods and compositions for treating hemophilia

granted A61KA61K48/00A61P

Quick answer

US patent 10407476 (Methods and compositions for treating hemophilia) held by Sangamo Therapeutics, Inc. expires Mon Sep 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sangamo Therapeutics, Inc.
Grant date
Tue Sep 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K48/00, A61P, A61P3/00, A61P43/00